David Carlile
Impact in
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- CAR-T cell therapy research
Papers in
- Oncology 34
- CAR-T cell therapy research 16
- Drug Transport and Resistance Mechanisms 12
-
- Lymphoma Diagnosis and Treatment 18
- Co-authors
- J. Brian Houston (5 shared papers)J. Brian Houston (6 shared papers)Martin K. Bayliss (2 shared papers)Katayoun Zomorodi (2 shared papers)Brian G. Lake (3 shared papers)Nancy Hakooz (3 shared papers)Alan R. Boobis (2 shared papers)Olavi Pelkonen (1 shared paper)
- Journals
- Blood (13 papers)Journal of Clinical Oncology (4 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)Xenobiotica (4 papers)Annals of Oncology (2 papers)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
David Carlile
54 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 101
- Pharmacology 844
- Oncology 1.1k
- Genetics 370
- Pathology and Forensic Medicine 534
- Immunology 266
Countries citing papers authored by David Carlile
This map shows the geographic impact of David Carlile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Carlile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Carlile more than expected).
Fields of papers citing papers by David Carlile
This network shows the impact of papers produced by David Carlile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Carlile. The network helps show where David Carlile may publish in the future.
Co-authors
The 25 scholars most cited alongside David Carlile, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 347 | |
| 2 | 2017 | 249 | |
| 3 | 1997 | 247 | |
| 4 | 2012 | 147 | |
| 5 | 2012 | 117 | |
| 6 | 1999 | 100 | |
| 7 | Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam. | 1997 | 100 |
| 8 | 2014 | 75 | |
| 9 | 1996 | 75 | |
| 10 | 2006 | 60 | |
| 11 | 1995 | 56 | |
| 12 | 2015 | 56 | |
| 13 | In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes. | 1998 | 50 |
| 14 | 2021 | 46 | |
| 15 | 2020 | 44 | |
| 16 | 2005 | 39 | |
| 17 | 1995 | 35 | |
| 18 | 2021 | 31 | |
| 19 | 2015 | 30 | |
| 20 | 2001 | 29 |
About David Carlile
David Carlile is a scholar working on Oncology, Pathology and Forensic Medicine, Pharmacology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 55 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (18 papers), CAR-T cell therapy research (16 papers), Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), Biosimilars and Bioanalytical Methods (6 papers) and Drug-Induced Hepatotoxicity and Protection (6 papers). The work is most often cited by research in Pharmacology (844 citations), Oncology (1.1k citations), Genetics (370 citations), Pathology and Forensic Medicine (534 citations) and Immunology (266 citations). David Carlile has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include J. Brian Houston, J. Brian Houston, Martin K. Bayliss, Katayoun Zomorodi, Brian G. Lake, Nancy Hakooz, Alan R. Boobis, Olavi Pelkonen, John C. Lipscomb and Robert J. Edwards. Their work appears in journals such as Blood, Journal of Clinical Oncology, CPT Pharmacometrics & Systems Pharmacology, Xenobiotica and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.